How to write in vitro and in vivo genotoxicity reports

How should a genotoxicity study report present its conclusion?

Identify the assay, genetic endpoint, test system and experimental conditions, then explain technical validity and the response interpretation separately. Preserve equivocal or discordant findings and their scientific assessment. For in vivo interpretation, make relevant exposure evidence traceable instead of treating a negative endpoint alone as a complete conclusion.

Before you begin

Reporting acquired genotoxicity evidence. The appropriate test battery and follow-up strategy depend on the product and program.

What you will prepare: A report in which assay outcomes, validity and the scientific interpretation can be traced separately.

State the genetic endpoint and test system

The genotoxicity family separates in vitro (4.2.3.3.1) from in vivo (4.2.3.3.2) evidence. Identify the actual assay and genetic endpoint in the title and opening paragraph. A bacterial mutation test, a mammalian-cell assay and an in vivo endpoint do not answer identical questions.

S2(R1) addresses testing and interpretation, including equivocal results and follow-up. Use the applicable parts with the study scientist; the heading alone does not select the battery. Where a novel product or test system changes the usual approach, record the scientific and regulatory rationale rather than claiming that a familiar assay title establishes applicability.

Make the in vitro interpretation inspectable

Collect the protocol, test-system identity, test-article characterization, treatment conditions, metabolic-activation conditions where relevant, concentration selection, control data, assay outputs and the documented interpretation criteria. Keep technical validity distinct from the response classification.

As an editorial review method, put each experiment's outcome beside its control performance, cytotoxicity or interference observations, and the analysis actually performed. Explain exclusions and any repeat experiment through the contemporaneous rationale. A favorable repeat cannot simply replace an unfavorable original. If the report conclusion is equivocal, retain that word and its reasoning; the publishing process is not a reason to force a binary result.

Connect the in vivo endpoint to exposure evidence

For in vivo work, describe the animal population, administration, collection time, tissue or cell population examined and endpoint assessment. Identify the evidence used to judge whether the relevant system was exposed, and explain uncertainties. Absence of a detected response is less informative when the experiment's exposure or technical validity is unresolved.

Keep supporting toxicokinetic data linked to the correct study and sample context. If exposure evidence comes from another experiment, identify it explicitly and ask the scientist to assess whether it supports the interpretation. Do not silently transfer a concentration measured with a different route or formulation into the report.

Handle discordant results without erasing them

Fictional example: an in vitro experiment has an equivocal response; a later experiment is negative, but it used different concentration conditions. The proposed summary calls the whole program negative without discussing the difference.

The reviewer should compare the protocols, control performance, concentration conditions and the documented rationale for the later study. Ask the genotoxicity lead to reconcile the findings. The resulting report may support a qualified interpretation, require additional explanation or remain unresolved. Do not claim that a negative later result automatically invalidates earlier evidence.

Before handoff, compare the individual report conclusions with the corresponding Module 2 narrative and tables. Preserve the experiment identifiers and material qualifications so the reviewer can follow the reasoning rather than counting positive and negative labels.

Keep validity, response and follow-up in separate columns

Use an experiment ledger when a report contains repeats, modified conditions or follow-up work. The purpose is to make the reasoning visible, not to count experiments as votes.

Keep original results retrievable even when the overall interpretation changes. A valid positive, an equivocal result and an uninterpretable experiment are different states; a binary spreadsheet can obscure those differences. Record the study scientist's terminology and rationale accurately.

Writing exercise: two reports have different conclusions but also use different conditions. Instead of “the second test cleared the first,” explain what changed, what each experiment demonstrated and how the responsible scientist reconciled them. If a reconciliation is missing, flag that interpretive gap rather than choosing the more favorable conclusion.

Before writing the program-level statement, compare this ledger with the toxicology summary. Link supporting exposure records through the ADME guide where relevant. The summary should retain important limits on interpretation without reproducing every assay record.

Frequently asked questions

Sources and revisions

Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.

Related guides